BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 29, Issue 8
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (18126)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.
Item 
Count 
PDF713
WORD60
HTML12768
Figures (1-1)876
Tables (1-2)863
 Sum=15280
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse351
Download1119
 Sum=1470
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse426
Download943
 Sum=1369
Feb 28, 2023 (publication date) through May 5, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, Imbriani S, Claar E, Cozzolino D, Sasso FC, Marrone A, Adinolfi LE, Rinaldi L. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroenterol 2023; 29(8): 1243-1260 [PMID: 36925456 DOI: 10.3748/wjg.v29.i8.1243]
URL: https://www.wjgnet.com/1007-9327/full/v29/i8/1243.htm
Number Citing Articles
1
Abdullah Altaf, Yutaka Endo, Muhammad M. Munir, Muhammad Muntazir M. Khan, Zayed Rashid, Mujtaba Khalil, Alfredo Guglielmi, Francesca Ratti, Hugo Marques, François Cauchy, Vincent Lam, George Poultsides, Minoru Kitago, Irinel Popescu, Guillaume Martel, Ana Gleisner, Tom Hugh, Feng Shen, Itaru Endo, Timothy M. Pawlik. Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma. HPB 2024; 26(8): 1040 doi: 10.1016/j.hpb.2024.05.006
2
Alessandro Vitale, Marco Brolese, Ilaria Govoni, Chiara Naldini, Nicola Canitano, Enrico Gringeri, Francesco D’Amico, Domenico Bassi, Francesco Enrico D’Amico, Jacopo Lanari, Alessandro Furlanetto, Virginia Padoan, Daniel Salinas, Umberto Cillo. Laparoscopic Microwave Ablation and Salvage Liver Transplantation in Patients with Hepatocellular Carcinoma. Cancers 2025; 17(13): 2248 doi: 10.3390/cancers17132248
3
Shenyu Zhang, Guibin Yang, Ruipeng Song, Wei Wang, Fanzheng Meng, Dalong Yin, Jiabei Wang, Shugeng Zhang, Wei Cai, Yao Liu, Dayong Luo, Jizhou Wang, Lianxin Liu. Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experience. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241258394
4
Jinhong Zhao, Miaoping Zhou, Yongjie Zhou, Yongming Tan, Wenjie Jiang, Lufang Tong, Zhili Yang, Liangxia Xiong, Rong Chen, Lianggeng Gong, Jinqiu Deng, Xiang Wei, Zhichao Zuo, Zhiqiang Wang. CT-Based Nested Habitats Analysis for Early Recurrence Prediction and Risk Stratification in Hepatocellular Carcinoma: Development and Multicenter Validation Across Four Cohorts. Annals of Surgical Oncology 2026;  doi: 10.1245/s10434-026-19361-2
5
Quratul Abedin, Kulsoom Bibi, Alex von Kriegsheim, Zehra Hashim, Amber Ilyas. Identification of Potential Hub Proteins as Theragnostic Targets in Hepatocellular Carcinoma through Comprehensive Quantitative Tissue Proteomics Analysis. Cancer Informatics 2025; 24 doi: 10.1177/11769351251336923
6
Da Guo, Liping Liu, Yu Jin. Prediction early recurrence of hepatocellular carcinoma after hepatectomy using gadoxetic acid-enhanced MRI and IVIM. European Journal of Radiology Open 2025; 14: 100643 doi: 10.1016/j.ejro.2025.100643
7
Jiaqi Wang, Oscar Wai-Ho Yeung, Wenqi Qiu, Li Pang, Jiang Liu, Xinxiang Yang, Shinuan Zeng, Tao Ding, Zhe Wang, Zhenhua Hu, Tan To Cheung, Kwan Man, Kevin Tak-Pan Ng. CCL11 promotes hepatocellular carcinoma recurrence after surgery by potentiating immunosuppressive CCR5 + CD206 + M2-like macrophages and promoting tumor invasiveness. Cell Death & Disease 2026; 17(1) doi: 10.1038/s41419-026-08508-4
8
Xinxin Wang, Yanyan Yu, Yuqing Tao, Yueqi Wang, Chunhui Zhang, Yali Cui, Yang Zhou. Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients. Journal of Hepatocellular Carcinoma 2023; : 2323 doi: 10.2147/JHC.S434955
9
Chaowen Xiao, Xinyang Zhao, Zouxiao Hu, Guanbao Long. MFSD2A Overexpression Inhibits Hepatocellular Carcinoma Through TGF‐β/Smad Signaling. Molecular Carcinogenesis 2025; 64(3): 597 doi: 10.1002/mc.23875
10
Juan Jose Urquijo-Ponce, Carlos Alventosa-Mateu, Mercedes Latorre-Sánchez, Inmaculada Castelló-Miralles, Moisés Diago. Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(19): 2512-2522 doi: 10.3748/wjg.v30.i19.2512
11
Zhenyao Tan, Yezhen Tang, Bendong Chen, Yongxue Lv, Bozhi Zhang, Kejun Liu, Yang Bu. Single‐Cell Multi‐Omics Reveals B2M‐Mediated Myeloid Reprogramming and Constructs a Predictive Model for Early Hepatocellular Carcinoma Recurrence. The FASEB Journal 2025; 39(24) doi: 10.1096/fj.202503144R
12
Bing-Bing Su, Chao-Jie Zhu, Jun Cao, Rui Peng, Dao-Yuan Tu, Guo-Qing Jiang, Sheng-Jie Jin, Qian Wang, Chi Zhang, Dou-Sheng Bai. Enhanced prediction of 5-year postoperative recurrence in hepatocellular carcinoma by incorporating LASSO regression and random forest models. Surgical Endoscopy 2025; 39(4): 2540 doi: 10.1007/s00464-025-11631-6
13
Zhan‐cheng Qiu, You‐wei Wu, Wei‐li Qi, Chuan Li. PIVKA‐II combined with tumor burden score to predict long‐term outcomes of AFP‐negative hepatocellular carcinoma patients after liver resection. Cancer Medicine 2024; 13(1) doi: 10.1002/cam4.6835
14
Rex Wan-Hin Hui, Keith Wan-Hang Chiu, I-Cheng Lee, Chenlu Wang, Ho-Ming Cheng, Jianliang Lu, Xianhua Mao, Sarah Yu, Lok-Ka Lam, Lung-Yi Mak, Tan-To Cheung, Nam-Hung Chia, Chin-Cheung Cheung, Wai-Kuen Kan, Tiffany Cho-Lam Wong, Albert Chi-Yan Chan, Yi-Hsiang Huang, Man-Fung Yuen, Philip Leung-Ho Yu, Wai-Kay Seto. Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgery. Hepatology 2025; 82(2): 344 doi: 10.1097/HEP.0000000000001180
15
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
16
Kai-Di Wang, Ming-Jing Guan, Zi-Yang Bao, Zhe-Jin Shi, Hai-Hang Tong, Zun-Qiang Xiao, Lei Liang, Jun-Wei Liu, Guo-Liang Shen. Radiomics analysis based on dynamic contrast-enhanced MRI for predicting early recurrence after hepatectomy in hepatocellular carcinoma patients. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-02291-6
17
Andreea-Elena Scheau, Sandra Oana Jurca, Cristian Scheau, Ioana Gabriela Lupescu. Non-Surgical Treatment for Hepatocellular Carcinoma: What to Expect at Follow-Up Magnetic Resonance Imaging—A Pictorial Review. Applied Sciences 2024; 14(20): 9159 doi: 10.3390/app14209159
18
Natalia Afonso-Luis, Irene Monescillo-Martín, Joaquín Marchena-Gómez, Pau Plá-Sánchez, Francisco Cruz-Benavides, Carmen Rosa Hernández-Socorro. Concordance Index-Based Comparison of Inflammatory and Classical Prognostic Markers in Untreated Hepatocellular Carcinoma. Journal of Clinical Medicine 2025; 14(15): 5514 doi: 10.3390/jcm14155514
19
Carlos Alventosa-Mateu, Juan José Urquijo Ponce. Present and future of systemic therapy for early and intermediate stages of hepatocellular carcinoma. Revisiones en Cáncer 2025;  doi: 10.20960/revcancer.00104
20
Ding-Fan Guo, Qi Wen, Xiang Zhang, Jian Luo, Lin-Wei Fan, Yun-Hui Liang, Qi Feng, Ting Wang, Kun-He Zhang. An interpretable machine learning model using routine clinical data for early recurrence prediction in hepatocellular carcinoma. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-38484-w
21
Pengtao Chen, Yinan Ding, Jie Lin, Zhengxiao Ma, Xinyu Miao, Yue Zhuo, Chenhang Sun, Chanjuan Peng, Han Lin, Jiaping Zheng, Xiaoxia Wu, Dinghu Zhang. Inhibitory effect of photothermal therapy mediated by a neutrophil-based inflammation-targeted drug delivery system on tumor recurrence following hepatocellular carcinoma ablation. Chinese Chemical Letters 2026; : 112881 doi: 10.1016/j.cclet.2026.112881
22
Single cell analysis and bioinformatics reveal pyroptosis mechanisms in hepatocellular carcinoma. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02907-3
23
Hwee‐Leong Tan, Claudia Y. T. Liauw, Tse‐Lert Chua, Amanda Y. R. Lam, Cliburn Chan, Ye‐Xin Koh, Jin‐Yao Teo, Peng‐Chung Cheow, Alexander Y. F. Chung, Brian K. P. Goh. Comparison Between Cox Proportional Hazards and Machine Learning Models for the Prognostication of Recurrence and Survival Following Liver Resection for Hepatocellular Carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2025; 32(10): 745 doi: 10.1002/jhbp.12186
24
Meilin Yang, Xiaoyi Song, Fan Zhang, Mingan Li, Wuguang Chang, Zheyan Wang, Man Li, Hong Shan, Dan Li. Spatial proteomic landscape of primary and relapsed hepatocellular carcinoma reveals immune escape characteristics in early relapse. Hepatology 2025; 81(5): 1452 doi: 10.1097/HEP.0000000000000979
25
Guodong Wu, Xia Ou, Mengda Zou, Feng Xia, Leida Zhang, Kai Feng, Kuansheng Ma, Qiang Wang. No-touch versus conventional radiofrequency ablation for treating solitary recurrent hepatocellular carcinoma ≤ 3 cm: a retrospective cohort study. Journal of Cancer Research and Clinical Oncology 2026; 152(3) doi: 10.1007/s00432-026-06453-5
26
Jusen Nong, Kejian Yang, Tianman Li, Chenlu Lan, Xin Zhou, Junqi Liu, Haixiang Xie, Jianzhu Luo, Xiwen Liao, Guangzhi Zhu, Tao Peng. SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma. Aging 2023; 15(16): 8408 doi: 10.18632/aging.204978
27
Noura Gamal, Rasha Abdelhafiz Aly, Alzhraa Alkhatib, Asmaa Gomaa, Naglaa Allam, Imam Waked. Adjuvant anti-PD-L1 therapy for hepatocellular carcinoma following curative treatment: case series. Egyptian Liver Journal 2026; 16(1) doi: 10.1186/s43066-025-00460-w
28
Han Shi, Caixia Hu. A prediction model based on machine learning: prognosis of HBV-induced HCC male patients with smoking and drinking habits after local ablation treatment. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1464863
29
Jinfeng Wang, Guangjie Han, Xin Han, Jianfei Shi, Lili Mi, Ning Li, Man Zhao, Xiaoling Duan, Fei Yin. A blood-biomarker based CTC-ALRI score predicts recurrence in hepatocellular carcinoma patients following curative resection. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1788776
30
JiaYi Li, Yinxin Wu, Dingyin Zhang, Ziyan Zhang, Songqiang Li, Xi Cheng, Lihan Chen, Gang Zhou, Chengfu Yuan. The Roles of Cytoplasmic Polyadenylation Element Binding Protein 1 in Tumorigenesis. Mini-Reviews in Medicinal Chemistry 2024; 24(22): 2008 doi: 10.2174/0113895575293544240605112838
31
Yongyi Cen, Haiyang Nong, Dehui Du, Yingning Wu, Jianpeng Chen, Zhaolin Pan, Yin Huang, Ke Ding, Deyou Huang. CT-Based 2.5D Deep Learning-Multi-Instance Learning for Predicting Early Recurrence of Hepatocellular Carcinoma and Correlating with Recurrence-Related Pathological Indicators. Journal of Hepatocellular Carcinoma 2025; : 2095 doi: 10.2147/JHC.S541402
32
Qi Fan, Pengcheng Wei, Delin Ma, Qian Cheng, Jie Gao, Jiye Zhu, Zhao Li. Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study. Surgery Open Science 2025; 23: 16 doi: 10.1016/j.sopen.2024.12.004
33
Yusra Zarlashat, Hassan Mushtaq, Linh Pham, Wasim Abbas, Keisaku Sato. Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies. International Journal of Molecular Sciences 2024; 25(13): 6830 doi: 10.3390/ijms25136830
34
Qian Ren, Yanjun Wang. Letter to the Editor: Comment on: “LI‑RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection”. Annals of Surgical Oncology 2023; 30(13): 8023 doi: 10.1245/s10434-023-14444-w
35
Jun Shibamoto, Michihisa Moriguchi, Akifumi Notsu, Keita Mori, Ryo Ashida, Katsuhisa Ohgi, Shimpei Otsuka, Yoshiyasu Kato, Hideyuki Dei, Katsuhiko Uesaka, Teiichi Sugiura. Prognostic impact and predictive model for early non-curative recurrence after liver resection for hepatocellular carcinoma: a retrospective cohort study. International Journal of Surgery 2026; 112(1): 1233 doi: 10.1097/JS9.0000000000003534
36
V. V. Petkau, R. I. Rasulov, A. A. Muratov, G. V. Nurbekyan, I. B. Uvarov, A. A. Kirshin, R. V. Orlova, N. V. Popova, M. S. Dinikin, R. Yu. Khlobystin, A. V. Sultanbaev, K. V. Menshikov, O. G. Orlov. Long-term results of surgical treatment of hepatocellular cancer in Russian real practice. Meditsinskiy sovet = Medical Council 2024; (21): 114 doi: 10.21518/ms2024-422
37
Defeng Yuan, Feng Zhang, Pengfei Lv, Jun Zhu, Haiwei Zhang, Zhengcong Zhang. A reliable prognostic model for hepatocellular carcinoma using neutrophil extracellular traps and immune related genes. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-01335-1
38
Yubo Zhang, Hongyan Ma, Peng Lei, Zhiyuan Li, Zhao Yan, Xinqing Wang. Prediction of early postoperative recurrence of hepatocellular carcinoma by habitat analysis based on different sequence of contrast-enhanced CT. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1522501
39
Xiaoyu Zhang, Rui Li, Wei Chen, Yufu Ye, Yifan Hong, Yiwen Chen, Xiang Li, Wendi Hu, Zhenglong Zhai, Jiaqi Yang, Yan Shen, Min Zhang, Jian Wu, Shunliang Gao, Jun Yu, Risheng Que, Xueli Bai, Tingbo Liang. Robotic vs. open liver resection after neoadjuvant therapy for hepatocellular carcinoma: a propensity score-matched analysis of short- and long-term outcomes. Surgical Endoscopy 2026;  doi: 10.1007/s00464-026-12682-z
40
Bingqiang Zhang, Boyang Zhu, Junmei Yu, He Liu, Yang Zhou, Guolong Sun, Yongchao Ma, Yansong Luan, Mengmeng Chen. A combined model of six serum microRNAs as diagnostic markers for hepatocellular carcinoma. Clinica Chimica Acta 2025; 565: 119977 doi: 10.1016/j.cca.2024.119977
41
Tao Sun, Xiangkun Wang, Guangcan Zhu, Jinfu Zhang, Juan Huang, Renfeng Li, Xinguang Qiu. The EZ-ALBI and PALBI scores contribute to the clinical application of ALBI in predicting postoperative recurrence of HCC. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-93716-9
42
Riccardo Nevola, Giovanni Tortorella, Valerio Rosato, Luca Rinaldi, Simona Imbriani, Pasquale Perillo, Davide Mastrocinque, Marco La Montagna, Antonio Russo, Giovanni Di Lorenzo, Maria Alfano, Maria Rocco, Carmen Ricozzi, Klodian Gjeloshi, Ferdinando Carlo Sasso, Raffaele Marfella, Aldo Marrone, Loreta Anesti Kondili, Nicolino Esposito, Ernesto Claar, Domenico Cozzolino. Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma. Biology 2023; 12(7): 984 doi: 10.3390/biology12070984
43
Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang. KDM4A-AS1 Promotes Cell Proliferation, Migration, and Invasion via the miR-4306/STX6 Axis in Hepatocellular Carcinoma . Critical Reviews in Eukaryotic Gene Expression 2024; 34(4): 55 doi: 10.1615/CritRevEukaryotGeneExpr.2024051414
44
Mario Romeo, Marcello Dallio, Carmine Napolitano, Claudio Basile, Fiammetta Di Nardo, Paolo Vaia, Patrizia Iodice, Alessandro Federico. Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?. Diagnostics 2025; 15(3): 252 doi: 10.3390/diagnostics15030252
45
Guoqun Zheng, Minjie Zheng, Peng Hu, Yu Zhu, Wenlong Zhang, Fabiao Zhang. Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2025; : 539 doi: 10.2147/JHC.S510581
46
Lingbo Hu, Cong Chen, Yanhong Xiao, Zhenghang Li, Ning Jiang, Chengyou Du, Guirong Lv, Jun Tang, Bo Zeng. Prognostic impact of tertiary lymphoid structures and cancer-associated fibroblasts in hepatocellular carcinoma with portal vein tumor thrombus. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-28296-9
47
Xu Feng, Yi-Qiu Wei, Jia-Rui Liu, Zheng-Rong Shi, Kai Chen, Yong-Shuang Lv. The therapeutic efficacy of radical resection for hepatocellular carcinoma varies markedly by tumor location: a retrospective real-world study. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1674998
48
Suyang Yue, Qin Ding, Shanzhong Tan, Pengpeng Zhang. SPP1+ Macrophage‐Associated Prognostic Signature in Hepatocellular Carcinoma via Integrated Single‐Cell and Bulk Transcriptomic Analysis. International Journal of Genomics 2025; 2025(1) doi: 10.1155/ijog/5555332
49
Qinggang Tian, Hui Zhang, Zhe Hu, Jianxin Jia, Yunqi Hua, Yanting Wu. A retrospective cohort study on the protective role of 3D-Printed CT/MRI-based models in preventing vascular injury during hepatectomy. Journal of Radiation Research and Applied Sciences 2025; 18(4): 102054 doi: 10.1016/j.jrras.2025.102054
50
Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee, Do Young Kim. Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma. Cancers 2025; 17(4): 566 doi: 10.3390/cancers17040566
51
Wenxia Shi, Jingjing Dong, Hailin Li, Li Jing, Hua Guo, Tong Liu, Chenglong Li, Yingtang Gao. The Long Non-Coding RNA SNHG16 Negatively Regulates Let-7 and Predicts Recurrence in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2025; : 2393 doi: 10.2147/JHC.S548493
52
Mingjie Lu, Chen Wang, Yi Zhuo, Junjiu Gou, Yingfeng Li, Jingqi Li, Xue Dong. Preoperative prediction power of radiomics and non-radiomics methods based on MRI for early recurrence in hepatocellular carcinoma: a systemic review and meta-analysis. Abdominal Radiology 2024; 49(10): 3397 doi: 10.1007/s00261-024-04356-y
53
Eloy Ruiz, Jorge Honles, Ramiro Fernández, Karla Uribe, Juan P. Cerapio, Karina Cancino, Juan Contreras-Mancilla, Sandro Casavilca-Zambrano, Francisco Berrospi, Pascal Pineau, Stéphane Bertani. A preoperative risk score based on early recurrence for estimating outcomes after resection of hepatocellular carcinoma in the non-cirrhotic liver. HPB 2024; 26(5): 691 doi: 10.1016/j.hpb.2024.02.010
54
Jinhai Wang, Li Ma, Jinjuan Wang, Zhe Ma, Weiwei Wang, Songning Yu. Circadian rhythm-based prognostic features predict immune infiltration and tumor microenvironment in molecular subtypes of hepatocellular carcinoma. Open Life Sciences 2025; 20(1) doi: 10.1515/biol-2025-1208
55
Yanping Chen, Baoru Fang, Ke Wang, Siqi Geng, Fang Wang, Lin Xu, Zhiqiu Ye, Fei Xu, Zhangsen Yu. Targeted Thermosensitive Ultrasound Contrast Agent-Enabled Ultrasound-Guided Precise Radiofrequency Ablation/Immunotherapy Synergistic Treatment for Hepatocellular Carcinoma. ACS Applied Nano Materials 2026; 9(11): 5117 doi: 10.1021/acsanm.5c05849
56
Yanxing Mai, Zhuocheng Ji, Yujing Tan, Lei Feng, Jiasheng Qin. BIRC5 knockdown ameliorates hepatocellular carcinoma progression via regulating PPARγ pathway and cuproptosis. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01592-y
57
Chien-Hao Huang, Wei-Ting Ku, Jayashri Mahalingam, Cheng-Heng Wu, Tsung-Han Wu, Jian-He Fang, Chung-Wei Su, Po-Ting Lin, Chien-Wei Peng, Chan-Keng Yang, Wei Teng, Wen-Juei Jeng, Wei-Ting Chen, Chen-Chun Lin, Shi-Ming Lin, I-Shyan Sheen, Yung-Chang Lin, Chun-Yen Lin. Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in HCC. Hepatology 2025;  doi: 10.1097/HEP.0000000000001428
58
Xuehan Shen, Wei Yan, Erlei Zhang, Zhiwei Zhang, Zunyi Zhang, Hanhua Dong. Adjuvant PD-1 inhibitors improve recurrence and survival outcomes in high-risk hepatocellular carcinoma patients after curative hepatectomy. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02444-3
59
Chunhui Liu, Wenqi Zhang, Wenzi Luo, Caifeng Zhang, Bo Zhang, Guozhi Zhang, Xiaotao Wang, Jianli Chen, Han Zhou. Integrating bulk RNA-seq and ScRNA-seq to identify manganese metabolism-related subtypes and immunoregulatory mechanisms in liver hepatocellular carcinoma. Open Life Sciences 2026; 21(1) doi: 10.1515/biol-2025-1298
60
Dong Hyun Kim, Hye Won Lee. Letter on ‘Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma’. Alimentary Pharmacology & Therapeutics 2025; 62(2): 236 doi: 10.1111/apt.70210
61
Jun Lv, Fu-yuan Gan, Ming-hao Li, Qing-jun Yin. MRPL42 Knockdown Suppresses the Malignant Functions of Hepatocellular Carcinoma by Regulating Oxidative Phosphorylation. Current Medical Science 2026; 46(2): 483 doi: 10.1007/s11596-026-00176-x
62
Jin-Lei Wang, Jia-Ping Yan, Jia-Ru Fan, Xiang Li, Xu Guo, Jia-Wei Li, Yun-Xiaojian Wu, Jing-Jie Wang, Yu-Lu Chen, Li Li, Cong Lin, Xin-Liang Qu, Ji-Hong Liu, Yan-Liang Zhang, Ying-Yi Yuan, Hua-Ge Yu, Yu-Xi Chen, Yi-Xuan Cai, Xiang-Di Zhang, Si Zhao, Zi-Hang Xu, Li Ma, Na Ma, Diao-Mei Guo, Lian-Sheng Ma. 2023: A year of accomplishments for the 13 Science Citation Index Expanded- and Emerging Sources Citation Index-indexed <i>Baishideng</i> journals. World Journal of Gastroenterology 2024; 30(1): 9-16 doi: 10.3748/wjg.v30.i1.9
63
Yuan Tian, Yaoqun Wang, Ningyuan Wen, Shaofeng Wang, Bei Li, Geng Liu. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12162-4
64
Anna S. Samuel, Andee Qiao, Christina D. Merrill, Chad G. Ball, David Burrowes, Stephanie R. Wilson. The post-surgical liver: is application of treatment response assessment within the CEUS LI-RADS framework possible?. Abdominal Radiology 2025; 50(12): 5761 doi: 10.1007/s00261-025-05046-z
65
Yuanyue Guan, Jiaxi Li, Bin Sun, Kaikun Xu, Yonghong Zhang, Haijing Ben, Yingmei Feng, Mengcheng Liu, Shanshan Wang, Yuxue Gao, Zhongping Duan, Yang Zhang, Dexi Chen, Yanjun Wang. HBx-induced upregulation of MAP1S drives hepatocellular carcinoma proliferation and migration via MAP1S/Smad/TGF-β1 loop. International Journal of Biological Macromolecules 2024; 281: 136327 doi: 10.1016/j.ijbiomac.2024.136327
66
Lijuan Feng, Ningbin Luo, Fengqiu Ruan, Xihuan Zheng, Xiaoyu Pan, Xuan Li, Liang Fu, Liling Long. Machine learning integrating MRI and clinical features predicts early recurrence of hepatocellular carcinoma after resection. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-36261-3
67
Fan Rong, Bin Cheng, Ling Guo, Shaobo Zeng, Xunliang Xu, Zhongji Meng, Matthew Cserhati. Correlation analysis of mitochondrial DNA maintenance-related genes with HCC prognosis, tumor mutation burden and tumor microenvironment features. PLOS One 2025; 20(6): e0325033 doi: 10.1371/journal.pone.0325033
68
Faezeh Sharafi, Elham Rismani, Mohamad Rhmanian, Arezoo Khosravi, Ali Zarrabi, Massoud Vosough. Mitochondrial dysfunction in hepatocellular carcinoma: from metabolism to targeted therapies. Molecular and Cellular Biochemistry 2025; 480(12): 6015 doi: 10.1007/s11010-025-05377-x
69
Ye Lu, Huanhuan Wang, Chenxia Li, Ferdos Faghihkhorasani, Cheng Guo, Xin Zheng, Tao Song, Qingguang Liu, Shaoshan Han. Preoperative and postoperative MRI-based models versus clinical staging systems for predicting early recurrence in hepatocellular carcinoma. European Journal of Surgical Oncology 2024; 50(9): 108476 doi: 10.1016/j.ejso.2024.108476
70
Jin Sun. Dystrobrevin beta is a promising prognostic biomarker and therapeutic target for hepatocellular carcinoma. American Journal of Translational Research 2024; 16(10): 6072 doi: 10.62347/FCFO5076
71
Mohammad SS Naviwala, Waqas A Khan, Adeeba Zaki, Mahnoor Tariq, Faiza Ahmed, Warda Saleem, Munira Moosajee, Yasmin A Rashid. Overall Survival and the Impact of Albumin-bilirubin Grade in Patients with Advanced Hepatocellular Carcinoma: Data from a Tertiary Care Hospital in a Lower-middle-income Country. Euroasian journal of hepato-gastroenterology 2024; 14(2): 251 doi: 10.5005/jp-journals-10018-1447
72
LINGLI ZHANG, YAN LI, JINGXIN MAO. Research progress on natural products against hepatocellular carcinoma. BIOCELL 2024; 48(6): 905 doi: 10.32604/biocell.2024.050396
73
Juncheng Guo, Kaiqiong Wang, Qigang Sun, Jun Liu, Jinfang Zheng. Targeting B4GALT3 in BMSCs-EVs for Therapeutic Control of HCC via NF-κB pathway inhibition. Cell Biology and Toxicology 2025; 41(1) doi: 10.1007/s10565-025-10013-x
74
Shiye Yang, Haishun Ni, Aixian Zhang, Jixiang Zhang, Hong Zang, Zhibing Ming. Impact of postoperative morbidity on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: a multicenter observational study. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-024-85020-9
75
Bartholomew McKay, Edward Meehan, Lynn Chong, Ronan Motyer, Ashu Jhamb, Brett Knowles. Laparoscopic and Percutaneous Microwave Ablation for Hepatocellular Carcinoma—An Institutional Analysis of Complimentary Therapeutic Modalities. World Journal of Surgery 2025; 49(6): 1564 doi: 10.1002/wjs.12612
76
Ziyi Li, Yikai Hu, Zhuotian He, Heyi Xu, Hongyang Wang, Yufei He. Comparative transcriptomic and genomic analysis of tumor cells in the marginal and center regions of tumor nests in human hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1611951
77
Maria Conticchio, Emilie Uldry, Martin Hübner, Antonia Digklia, Montserrat Fraga, Christine Sempoux, Jean Louis Raisaro, David Fuks. Prognostic Factors in Colorectal Liver Metastases: An Exhaustive Review of the Literature and Future Prospectives. Cancers 2025; 17(15): 2539 doi: 10.3390/cancers17152539
78
Xuxia Zhu, Ping Lu, Liang Ji, Qingyu Liang. NDUFS8 facilitates hepatocellular carcinoma growth by enhancing mitochondrial function and escaping HUWE1-dependent degradation. Translational Oncology 2025; 61: 102521 doi: 10.1016/j.tranon.2025.102521
79
Jae Hyun Kwon, Eun-Kyoung Jwa, Jong Woo Lee, Eunyoung Tak, Shin Hwang. Development and validation of a dynamic prognostic nomogram for conditional survival in hepatocellular carcinoma: an analysis from the Korea Liver Cancer Registry. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-92500-z
80
Mariana Michelle Ramírez-Mejía, Nahum Méndez-Sánchez. From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoring. World Journal of Gastroenterology 2024; 30(7): 631-635 doi: 10.3748/wjg.v30.i7.631
81
Zhirong Zhang, Jiayao Yang, Rui Liu, Jing Ma, Kai Wang, Xiaojun Wang, Ni Tang. Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling. Genes & Diseases 2024; 11(5): 101285 doi: 10.1016/j.gendis.2024.101285
82
Wenying Qiao, Jiashuo Li, Yiqi Xiong, Jiasheng Zheng, Ronghua Jin, Caixia Hu. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation. Journal of Cancer Research and Clinical Oncology 2024; 150(5) doi: 10.1007/s00432-024-05760-z
83
Hong Song, Xiangyu Wang, Yunpeng Qin, Wanting Yang, Zhen Cheng, Jianhua Yang, Peizheng Yang, Biaobiao Yan, Ziyin Wu, Haiyang Sheng, Yinfeng Yang, Xiangyu Yang, Jinghui Wang. Decoding hepatocellular carcinoma prognosis: a machine learning-derived methylation signature integrating transcriptomic and tumor microenvironment insights. International Journal of Surgery 2026; 112(2): 3130 doi: 10.1097/JS9.0000000000003942
84
Zhenhui Lu, Jingzhe Yu, Tuoyu Lu, Siyuan Deng, Xuzhen Zheng, Baiyu Ji, Xiangyang Wu, Yingzi Yu. CD155 promotes the advancement of hepatocellular carcinoma by suppressing the p53-mediated ferroptosis via interacting with CD96. Journal of Molecular Medicine 2025; 103(3): 285 doi: 10.1007/s00109-025-02515-2
85
Zhijian Li, Lan Luo, Zhan Wang, Jie Hou. The Role of Cisplatin Prodrugs Bonded to Polymer Carriers for Nanodrug-targeted Treatment of In situ Hepatocellular Carcinoma. Anti-Cancer Agents in Medicinal Chemistry 2025; 25(19): 1564 doi: 10.2174/0118715206347681250312142125
86
Alessandro Ferrara, Claudia Brunori. Immigrant selectivity and second generation education in Italy: An aspiration squeeze?. Revista Internacional de Sociología 2025; 83(4): e286 doi: 10.3989/ris.2025.83.4.1499
87
Wenzhi Shu, Hao Chen, Ruolin Wang, Jiyong Song, Rui Tang, Guangdong Wu, Lihan Yu, Xuan Tong, Xiaojuan Wang, Yucheng Hou, Wen long Zhao, Lizhen Zhu, Jun Yan, Qian Lu. Machine perfusion prevents early tumor recurrence in liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study. Cancer Letters 2025; 633: 217970 doi: 10.1016/j.canlet.2025.217970
88
Haibin Tu, Siyi Feng, Lihong Chen, Yujie Huang, Juzhen Zhang, Xiaoxiong Wu. Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction. Medicine 2023; 102(35): e34937 doi: 10.1097/MD.0000000000034937
89
Fenglin Lv, Xinlu Zhang, Yanmei Wu, Zhipeng Li, Xiaomen Zheng, Huaxin Zhou, Wei Wang. eQTL and multi-omics integration reveal PPIH as a prognostic and immunotherapeutic biomarker. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1647722
90
Lorenzo Canova, Massimo Iavarone, Eleonora Alimenti, Mariangela Bruccoleri, Lorenzo Argiento, Riccardo Perbellini, Floriana Facchetti, Sara Uceda Renteria, Roberta D’Ambrosio, Elisabetta Degasperi, Anna Maria Ierardi, Angelo Sangiovanni, Matteo Vidali, Pietro Lampertico. ASAP score predicts early HCC recurrence after complete radiological response to locoregional treatments. Digestive and Liver Disease 2026; 58(2): 241 doi: 10.1016/j.dld.2025.12.018
91
Ning Zhang, Yongfa Zhang, Bingran Yu, Yixiu Wang, Miao Wang, Qi Pan, Anrong Mao, Weiping Zhu, Yiming Zhao, Ti Zhang, Lu Wang. Adjuvant HAIC combined with anlotinib and TQB2450 for resected high-risk hepatocellular carcinoma. The Innovation 2025; 6(7): 100910 doi: 10.1016/j.xinn.2025.100910
92
Honghai Zhang, Shugui Sheng, Wenying Qiao, Yu Sun, Ronghua Jin. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1395329
93
Xi Wang, Xinqun Chai, Ji Zhang, Ruiya Tang, Qinjunjie Chen. Nomograms established for predicting microvascular invasion and early recurrence in patients with small hepatocellular carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12655-2
94
Baozhu Zhang, Muhammad Sohaib Iqbal, Yibin Yan, Han Wang, Xuejin Wang, Yinghe Zhang, Bing Guo. Next-generation dynamic and combinatorial nanotherapies for liver cancer: mechanisms, current advances and future perspectives. Journal of Nanobiotechnology 2026; 24(1) doi: 10.1186/s12951-026-04102-0
95
Zi-Chen Yu, Zhe-Jin Shi, Zheng-Kang Fang, Si-Yu Liu, Yang Yu, Kai-Di Wang, Dong-Sheng Huang, Guo-Liang Shen, Cheng-Wu Zhang, Lei Liang. Development and validation of machine learning-based model for predicting early recurrence for patients with HBV-associated hepatocellular carcinoma after curative hepatectomy. The American Journal of Surgery 2026; 251: 116716 doi: 10.1016/j.amjsurg.2025.116716
96
Fabio Giannone, Gianluca Cassese, Antonio Cubisino, Emanuele Felli, Federica Cipriani, Bruno Branciforte, Rami Rhaiem, Alessandro Tropea, Edoardo Maria Muttillo, Andrea Scarinci, Bader Al Taweel, Raffaele Brustia, Ephrem Salame, Daniele Sommacale, Salvatore Gruttadauria, Tullio Piardi, Gian Luca Grazi, Guido Torzilli, Luca Aldrighetti, Mickael Lesurtel, Ho-Seong Han, Fabrizio Panaro, Patrick Pessaux. Patterns of Site and Timing of Recurrence After Curative Resection in Single and Multiple Large Hepatocellular Carcinoma: A Multicenter International Comprehensive Analysis. Annals of Surgical Oncology 2025; 32(9): 6312 doi: 10.1245/s10434-025-17673-3
97
Yefeng Yao, Dan Song, Mengying Li, Songjie Wu, Weixuan Chen, Hanqi Xia, Ping Xu. Integrated Single‐Cell and Bulk Transcriptome Analysis Reveals the Prognostic Significance and Immune Regulatory Mechanisms of Sialylation in Hepatocellular Carcinoma. The FASEB Journal 2026; 40(4) doi: 10.1096/fj.202503688R
98
Pei‐Chang Lee, Tsung‐Yi Cheng, Chun‐Ting Ho, Kuo‐Wei Huang, Gar‐Yang Chau, Yi‐Hsiang Huang, Teh‐Ia Huo, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su. Gender Different Impacts of Muscle Mass and Adipose Tissue on Patients With Hepatocellular Carcinoma Undergoing Surgical Resection. Liver International 2025; 45(2) doi: 10.1111/liv.16237
99
Zhihui Chen, Changyan Zhang, Jialin Yang, Yong Peng. KLF1 Exerts Pro‐Tumour Role in Liver Cancer via Inhibiting ACSL4/LPCAT3‐Regulated Ferroptosis. Journal of Cellular and Molecular Medicine 2026; 30(3) doi: 10.1111/jcmm.71033
100
Christian M. Schürch. Liver cancer recurrence predicted by immune-cell location and gene expression. Nature 2025; 640(8060): 885 doi: 10.1038/d41586-025-00734-8
101
Kai Yu, Minqi Chen, Wanchao Hou, Jinhua Lu, Qianhan Liu, Wanrong Zeng, Zhengcai Du, Xiaotao Hou, Erwei Hao, Jiagang Deng, Peipei Gong. TMEM106C, BSG, COPE, CDCA8, KPNA2, LIG1, UQCRH, and CCT5: Predictive of Survival and Immunotherapy Resistance in Hepatocellular Carcinoma. Human Mutation 2026; 2026(1) doi: 10.1155/humu/1465989
102
Belinda Sánchez-Pérez, José M Ramia. Does enhanced recovery after surgery programs improve clinical outcomes in liver cancer surgery?. World Journal of Gastrointestinal Oncology 2024; 16(2): 255-258 doi: 10.4251/wjgo.v16.i2.255
103
Hyun Joo Lee, Moon Seok Choi, Byeong Geun Song, Won Seok Kang, Geum Youn Gwak, Myung Ji Goh, Yong Han Paik, Joon Hyeok Lee, Dong Hyun Sinn. Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment. Cancers 2024; 16(15): 2652 doi: 10.3390/cancers16152652
104
Jing Dong, Yin Gao, Penghui Li, Ping Chen, Yanxin Lv, Yanan Liu, Song Zhang, Minglong Zhang, Yu Wang. Oleanolic acid enhanced the anticancer effect of fluorouracil by regulating Ca2+ levels in hepatocellular carcinoma cells. Brazilian Journal of Medical and Biological Research 2025; 58 doi: 10.1590/1414-431x2025e14590
105
Hao Chen, Xiwen Wu, Xiaojun Zeng, Yu Wang, Yang Yi, Jian Yang, Chihua Fang. The application of augmented reality combined with indocyanine green fluorescence for guiding laparoscopic right hemihepatectomy in the treatment of hepatocellular carcinoma. European Journal of Surgical Oncology 2025; 51(9): 110146 doi: 10.1016/j.ejso.2025.110146
106
Kelley Núñez, Michael Schneider, Tyler Sandow, Juan Gimenez, Mina Hibino, Daniel Fort, Ari Cohen, Paul Thevenot. α-Fetoprotein, α-Fetoprotein-L3, and Des-γ-Carboxy Prothrombin Stratify Hepatocellular Carcinoma Treatment Response and Progression Risk. Gastro Hep Advances 2024; 3(3): 316 doi: 10.1016/j.gastha.2023.11.018
107
Xiaokun Chen, Xiangan Wu, Wei Peng, Liguo Liu, Xiao Liu, Xueshuai Wan, Haifeng Xu, Yongchang Zheng, Haitao Zhao, Yilei Mao, Xin Lu, Xinting Sang, Xiaoyan Chang, Kang Zhou, Jie Pan, Mei Guan, Dandan Hu, Haidong Tan, Yaojun Zhang, Shunda Du. Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study. Journal of Hepatocellular Carcinoma 2025; : 561 doi: 10.2147/JHC.S504016
108
蕊 秦. Analysis of Risk Factors and Prediction Models for Postoperative Recurrence of Hepatocellular Carcinoma. Advances in Clinical Medicine 2025; 15(11): 1599 doi: 10.12677/acm.2025.15113261
109
Yueming Cao, Maxwell Laurans, Ifeyinwa Onyiuke, Zenta Walther, Xuchen Zhang, Michal G. Rose, Tamar H. Taddei. Heterogeneous Tumor Profiles in Hepatocellular Carcinoma: An Example of Late Recurrences With Genetically Distinct Tumors Over a 10-Year Survival. ACG Case Reports Journal 2025; 12(4): e01670 doi: 10.14309/crj.0000000000001670
110
Manxia Zhou, Lin Zhu, Kaimin Zhang, Shanshan Wei, Haolun Wang, Songqing He, Xu Liu, Xialing Huang. Evaluation of therapeutic efficacy in hepatocellular carcinoma ablation based on CT radiomics and deep learning multimodal models. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1764094
111
Meng Fan. Systemic immunoinflammatory index and prognostic nutrition index for predicting pathologic responses of patients with advanced gastric cancer after neoadjuvant therapy for advanced gastric cancer. American Journal of Cancer Research 2024; 14(8): 3922 doi: 10.62347/PAYM2267
112
Hanh Ngo, Duy Nguyen, Minh-Xuan Dang, Thao Doan, Truc Thai. Early Recurrence of Hepatocellular Carcinoma in Patients without Microscopic Vascular Invasion: Clinicopathological Characteristics and Risk Factors. Journal of Hepatocellular Carcinoma 2025; : 1167 doi: 10.2147/JHC.S524683
113
Pengfei Yang, Mingxia Jiang, Kai Su, Dong Liu. Prediction of Microvascular Invasion in Recurrent Hepatocellular Carcinoma Prior to the Second Surgery Using Enhanced MRI and Variations in Clinical Features. Iranian Journal of Radiology 2025; 22(1) doi: 10.5812/iranjradiol-160728
114
Dongkai Gao, Zumo Zhou, Lin Chen, Jun Zheng, Jinna Yang. CGREF1 facilitates the cell proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of EIF3H/ Wnt/β-Catenin signaling axis. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-13808-7
115
Brandon M. Meyers, Howard J. Lim, Mayur Brahmania, Dave M. Liu, Vincent C. Tam, Deanna McLeod, Ravi Ramjeesingh, Jennifer J. Knox, Arndt Vogel. Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma. Therapeutic Advances in Medical Oncology 2025; 17 doi: 10.1177/17588359251357719
116
Chunhong Tian, Yifan Yu, Yuqing Wang, Lunwei Yang, Ying Tang, Chengyang Yu, Gaofei Feng, Dayong Zheng, Xiongwen Wang. Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1352873
117
Chunyi Zhu, Chuangye Han, Yongfei He, Shutian Mo, Youfang Wang, Jingren Shao, Tao Peng. Review of advances in FOLFOX-HAIC for conversion, neoadjuvant, and adjuvant therapy in hepatocellular carcinoma. Hepatoma Research 2026;  doi: 10.20517/2394-5079.2025.102
118
Zhi-Jun Zhang, Ba-Jin Wei, Zhi-Kun Liu, Ze-Feng Xuan, Lin Zhou, Shu-Sen Zheng. Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection. Hepatobiliary & Pancreatic Diseases International 2025; 24(3): 269 doi: 10.1016/j.hbpd.2024.09.006
119
Ying Li, Yuan Zhang, Wei Lu, Yun Chen, Xiaoling Qian. Artesunate inhibits hepatocellular carcinoma cell migration and invasion through OGA-mediated O-GlcNAcylation of ZEB1. Open Life Sciences 2025; 20(1) doi: 10.1515/biol-2025-1109
120
Mizelle D'Silva, Gurudutt Varty, Shraddha Patkar, Tanvi Shah, Prem Kamal Patnala, Sunil Vishwanathan, Kunal Gala, Vikas Ostwal, Rahul Krishnatry, Mahesh Goel. Navigating early recurrences in post-hepatectomy hepatocellular carcinoma: Preventive strategies and prognostic indicators. Surgical Oncology 2026; 66: 102438 doi: 10.1016/j.suronc.2026.102438
121
Rong-Gao Chen, Guan-Rong Chen, Xiao-Xiao Jiang, Ying-Chen Huang, Xin Hu, Wei-Liang Xia, Qi-Yang Cheng, Kun Wang, Xiao Xu, Shu-Sen Zheng. circ0006646 serves as a robust prognostic biomarker for post-transplant tumor recurrence and survival in hepatocellular carcinoma patients. Hepatobiliary & Pancreatic Diseases International 2025; 24(6): 616 doi: 10.1016/j.hbpd.2025.07.002
122
Ling-Bo Liang, Hai-Jun Zhang, Feng Liu, Qiao-Li Su. Hepatitis B core-related antigen as a predictive biomarker for recurrence in primary hepatocellular carcinoma: A meta-analysis. World Journal of Gastrointestinal Oncology 2025; 17(5): 105148 doi: 10.4251/wjgo.v17.i5.105148
123
Yangshuo Xia, Wu Wen, Yangyu Liao, Yingxiao Cai, Renhua Wan. Adjuvant Hepatic Arterial Infusion Chemotherapy Versus Transarterial Chemoembolization for Preventing Early Recurrence After Surgical Resection in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2025; : 1425 doi: 10.2147/JHC.S510814
124
Bufu Tang, Jiaqi Yang, Wangting Xu, Guangzhi Wang, Weishi Ye, Changyu Li, Juncheng Wan, Yongjie Zhou, Caihong Yu, Chaoqiao Jin, Zhiping Yan, Xudong Qu, Wen Zhang. Interventional therapy for hepatocellular carcinoma in the immunotherapy era: From mechanism exploration to materials innovation. Biomaterials 2026; 333: 124208 doi: 10.1016/j.biomaterials.2026.124208
125
Chunlong Zhao, Zheyu Zhou, Shuya Cao, Jinsong Liu, Jun Chen, Bing Han, Chaobo Chen, Xiaoliang Xu. The inflammatory state of tumor peripheral liver tissue affects hepatocellular carcinoma progression and prognosis. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-04726-6
126
Liping Zuo, Yueming An, Xiaoyun Liu, Bowen Wang, Linlin Lang, Zimeng Yang, Zhanyu Zhou, Weijia Zhao, Jinlei Fan, Xin Lin, Jingjing Chen, Na Zhu, Dexin Yu. Reduced visceral adipose tissue area linked to early recurrence in HCC patients with HBV: a parallel mediation analysis. Abdominal Radiology 2025;  doi: 10.1007/s00261-025-05287-y
127
Qingliang Song, Yilin Kong, Chuiyang Zheng, Dajin Pi, Wen Fan, Jianwei Zhen, Jinyue Pan, Lianghao Liu, Siyuan Huang, Fangyu Zhou, Qinhe Yang, Yupei Zhang, Maoxing Pan. Nomogram prediction of overall survival in patients with bone metastases from hepatocellular carcinoma: a SEER-based retrospective cohort study. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-06665-8
128
Sen Wang, Ying Zhao, Jiayi Li, Zongmin Yi, Jun Li, Can Zuo, Yu Yao, Ailian Liu. Self-supervised multi-modal feature fusion for predicting early recurrence of hepatocellular carcinoma. Computerized Medical Imaging and Graphics 2024; 118: 102457 doi: 10.1016/j.compmedimag.2024.102457
129
Jun Kawashima, Yutaka Endo, Mujtaba Khalil, Selamawit Woldesenbet, Miho Akabane, Andrea Ruzzenente, Francesca Ratti, Hugo Marques, Sara Oliveira, Jorge Balaia, François Cauchy, Vincent Lam, George Poultsides, Minoru Kitago, Irinel Popescu, Guillaume Martel, Ana Gleisner, Thomas J. Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Development and validation of a preoperative risk prediction model for severe complications and very early recurrence after liver resection for hepatocellular carcinoma. Surgery 2025; 185: 109527 doi: 10.1016/j.surg.2025.109527
130
Wei Shen, Lebin Yuan, Fei Cheng, Zhao Wu, Xiaodong Li. SRSF7 is a promising prognostic biomarker in hepatocellular carcinoma and is associated with immune infiltration. Genes & Genomics 2024; 46(1): 49 doi: 10.1007/s13258-023-01463-w
131
Myung Ji Goh, Hee Chul Park, Nalee Kim, Bong Kyung Bae, Moon Seok Choi, Jinsoo Rhu, Min Woo Lee, Woo Kyoung Jeong, Minji Kim, Kyunga Kim, Jeong Il Yu. Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma. Journal of Korean Medical Science 2024; 39(37) doi: 10.3346/jkms.2024.39.e251
132
Hideki Fujii, Takeshi Nishimura, Hiroyuki Kimura, Yasuhide Mitsumoto, Toshihide Shima, Yuya Seko, Michihisa Moriguchi, Seita Kataoka, Saiyu Tanaka, Hiroki Ishikawa, Shiro Takami, Yasuyuki Nagao, Atsushi Umemura, Yoshito Itoh, Kanji Yamaguchi. A novel scoring system to identify patients at low risk for hepatocellular carcinoma five years after DAA-Induced sustained virological response: a retrospective cohort study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04451-4
133
Liang Zhao, Qinghua Shu, Bowen Sha, Miao Wu, Yufeng Zhang. Preliminary analysis of the diagnostic value and mechanism of action of TGFbI and S100A4 in hepatocellular carcinoma. Journal of Medical Biochemistry 2025; 44(3): 400 doi: 10.5937/jomb0-54550
134
Wenjie Sun, Yafang Li, Haozhe Fu, Jiangze Li, Jinbao Li. Prophylactic transarterial chemoembolization after R0 resection is beneficial to improve the prognosis in hepatocellular carcinoma patients with microvascular invasion. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02722-w
135
Yu.M. Stepanov, N.Yu. Zavhorodnia, O.M. Vlasova. Hepatocellular carcinoma: current aspects of multidisciplinary management. Part 2. Treatment and prevention. GASTROENTEROLOGY 2026; 60(1): 52 doi: 10.22141/2308-2097.60.1.2026.718
136
Yang Haishen, Feiyu Jiang, Xinxin Si, Dan Sun, Haoran Fei, Dali Wang, Kai Li, Shengwang Du, Wei Hu, Zhong Wang. Expression of ALG8 in hepatocellular carcinoma and its diagnostic and prognostic significance. Scandinavian Journal of Gastroenterology 2025; 60(1): 62 doi: 10.1080/00365521.2024.2433562
137
Yutaka Endo, Muhammad Musaab Munir, Selamawit Woldesenbet, Erryk Katayama, Francesca Ratti, Hugo P Marques, François Cauchy, Vincent Lam, George A Poultsides, Minoru Kitago, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Ana Gleisner, Tom Hugh, Luca Aldrighetti, Feng Shen, Itaru Endo, Timothy M. Pawlik. Impact of Surgical Margin Width on Prognosis Following Resection of Hepatocellular Carcinoma Varies on the Basis of Preoperative Alpha-Feto Protein and Tumor Burden Score. Annals of Surgical Oncology 2023; 30(11): 6581 doi: 10.1245/s10434-023-13825-5
138
Wei Feng, Qing-Wang Ye, Qi-Le Wang, Si-Ying Chen, Yao Ma, Fan-Lai Meng. Predictors of one-year adverse outcomes after laparoscopic resection for hepatocellular carcinoma: Development and validation of an early-warning model. World Journal of Gastroenterology 2026; 32(6): 113195 doi: 10.3748/wjg.v32.i6.113195
139
Yu-An Su, Yung-Tsung Li, Hui-Lin Wu, Jia-Horng Kao, Pei-Jer Chen, Chun-Jen Liu. Microtubule-Associated Protein 4 Overexpression Correlates with Early Recurrence in Hepatitis B Virus-Associated Hepatocellular Carcinoma Patients Following Curative Hepatic Resection. Journal of Hepatocellular Carcinoma 2026; : 1 doi: 10.2147/JHC.S578725
140
Ji Zhang, Qing Chen, Yu Zhang, Jie Zhou. Construction of a random survival forest model based on a machine learning algorithm to predict early recurrence after hepatectomy for adult hepatocellular carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13366-4
141
Jeong Woo Kim, Chang Hee Lee. Preoperative Gadoxetic-Acid-Enhanced MRI Features Associated with Rapid Recurrence (<6 Months) After Curative Resection for Hepatocellular Carcinoma. Diagnostics 2026; 16(7): 1108 doi: 10.3390/diagnostics16071108
142
Jiaojiao Zheng, Siying Wang, Lei Xia, Zhen Sun, Kui Ming Chan, René Bernards, Wenxin Qin, Jinhong Chen, Qiang Xia, Haojie Jin. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-024-02075-w
143
Kunpeng Cao, Xinyue Wang, Chaoli Xu, Liuxi Wu, Lu Li, Ya Yuan, Xinhua Ye. Ultrasound-based Radiomics Analysis for Assessing Risk Factors Associated With Early Recurrence Following Surgical Resection of Hepatocellular Carcinoma. Ultrasound in Medicine & Biology 2024; 50(12): 1964 doi: 10.1016/j.ultrasmedbio.2024.09.002
144
Diski Saisa, Syifa Mustika, Mochamad Fachrureza, Stevanus Christian Surya, Derren Rampengan, Juan Alessandro Jeremis Maruli Nura Lele, Ammar Nojaid, Michael Owen Hogipranata. Effect of statin use on prognostic outcomes in hepatocellular carcinoma following liver surgery: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2026; 38(5): 527 doi: 10.1097/MEG.0000000000003110
145
Luca Ielasi, Enrico Fulco, Nicola Reggidori, Marco Domenicali, Francesco Giuseppe Foschi. Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications. Gastroenterology Insights 2024; 15(3): 599 doi: 10.3390/gastroent15030044
146
Neil Mehta, Kaushal Desai, Shital Kamble, Yan Song, Emily Gao, Usha Malhotra, Angie Lax, Sanjana Sundaresan, Nathaniel Downes, Adina Zhang, Abby Siegel. Recurrence-free survival as a predictor of overall survival among patients with early-stage hepatocellular carcinoma treated with surgical resection or local ablation. Surgical Oncology Insight 2026; 3(2): 100251 doi: 10.1016/j.soi.2026.100251
147
Zheng Song, Yu Zhang, Wei Luo, Chao Sun, Caihong Lv, Sihao Wang, Quanwei He, Ran Xu, Zhaofang Bai, Xiujuan Chang, Yongping Yang. HAND2-AS1 Promotes Ferroptosis to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma by TLR4/NOX2/DUOX2 Axis. Current Cancer Drug Targets 2025; 25(2): 144 doi: 10.2174/0115680096279597240219055135
148
Zhiyue Xie, Yanxia Wu, Nan Peng, Jing Wang, Hui Wang, Liang Zhao. BAIAP2L2 facilitates hepatocellular carcinoma progression and immune evasion of via targeting JAK1-mediated pathway and PD-L1 expression. Cancer Gene Therapy 2025; 32(4): 464 doi: 10.1038/s41417-025-00890-z
149
Longtao Liu, Lingling Qu, Xia Wu, Zhihao Wang, Shiyan He, Zhenyu Liu, Tong Zhang, Jie Wang, Shouye Zhao, Jing Lin. Detection and indications of circulating tumor cells in hepatocellular carcinoma. Analytical Methods 2025; 17(44): 8865 doi: 10.1039/D5AY01320H
150
Miho Akabane, Jun Kawashima, Selamawit Woldesenbet, Ghee Rye Lee, François Cauchy, Federico Aucejo, Irinel Popescu, Minoru Kitago, Guillaume Martel, Francesca Ratti, Luca Aldrighetti, George A. Poultsides, Yuki Imaoka, Andrea Ruzzenente, Itaru Endo, Ana Gleisner, Hugo P. Marques, Vincent Lam, Tom Hugh, Nazim Bhimani, Feng Shen, Timothy M. Pawlik. Distinct patterns of late recurrence in long-term hepatocellular carcinoma survivors. Journal of Gastrointestinal Surgery 2025; 29(9): 102135 doi: 10.1016/j.gassur.2025.102135
151
Yanyi Liu, Yanyan Zhang, Xinxin Wang, Hanyu Jiang, Wei Wang, Hongjun Li. MRI Radiomics-Based Evaluation of Vessels Encapsulating Tumor Clusters and Microvascular Invasion in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2026; : 1 doi: 10.2147/JHC.S578689
152
Shayan Sadrinasab, Sadaf Saket, Nadia Pourmohammadi, Fatemeh Khosravi, Masoud Saadat Fakhr. Modern therapeutic approaches for hepatic tumors: progress, limitations, and future directions. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02773-z
153
Dhruvajyoti Roy, Olaf Guckelberger, Elsie Oppermann, Ibrahim Büdeyri, Roxana Chaikhoun, Natascha Kohl, Michel Kostantin, Darius Zokai, Matthias Knaak, Shadi Katou, Felix Becker, Andreas Andreou, Haluk Morgul, Benjamin Struecker, Vladimir P. Zharov, Andreas Schnitzbauer, Thomas J. Vogl, Wolf O. Bechstein, Andreas Pascher, Markus S. Zimmermann, Mazen A. Juratli. Longitudinal monitoring of circulating tumor cell dynamics for potential prediction of early recurrence and clinical outcomes after curative resection of hepatocellular carcinoma: a pilot study. BMC Cancer 2026; 26(1) doi: 10.1186/s12885-026-15638-7
154
Jeanett Klubien, Lucas Alexander Knøfler, Peter Nørgaard Larsen, Christoph Tschuor, Torsten Pless, Eva Gadsbøll, Laurynas Kazlas, Anders Riegels Knudsen, Susanne Dam Nielsen, Hans-Christian Pommergaard. Nationwide study on survival and recurrence of hepatocellular carcinoma after ablation as first treatment. Surgical Oncology 2026; 65: 102391 doi: 10.1016/j.suronc.2026.102391
155
Kunyuan Jiang, Jingfei Li, Zihao Liu, Miao Chen, Wei Cai, Lianxin Liu, Dalong Yin. Impact of major hepatectomy on recurrence after resection of hepatocellular carcinoma at CNLC Ib stage: a propensity score matching study. International Journal of Surgery 2025; 111(1): 857 doi: 10.1097/JS9.0000000000001879
156
Jia‐Hao Law, Huilin Shao, Ramanuj DasGupta, Daniel Q. Huang. Developing risk stratification strategies and biomarkers for recurrent hepatocellular carcinoma. Clinical and Translational Medicine 2025; 15(8) doi: 10.1002/ctm2.70410
157
Xinting Pan, En Hu, Yang Zhou, Ling Li, Xinhui Huang, Zhixiong Cai. The prognostic nutritional index as a predictor of efficacy and early recurrence for adjuvant transarterial chemoembolization in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2024; 48(6): 102344 doi: 10.1016/j.clinre.2024.102344
158
Jinhong Zhao, Miaoping Zhou, Xiang Wei, Zhichao Zuo, Zhiqiang Wang. ASO Author Reflections: CT-Based Nested Habitats Analysis for Prognostication of Hepatocellular Carcinoma—Capturing Intratumoral Heterogeneity to Predict Early Recurrence. Annals of Surgical Oncology 2026;  doi: 10.1245/s10434-026-19508-1
159
A prognostic model based on gamma-glutamyl transpeptidase-derived neutrophil-platelet for predicting intrahepatic recurrence in hepatocellular carcinoma. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03997-9
160
Aoyun Hao, Changlei Li, Ruitao Sun, Bin Tan, Guanming Shao, Kun Li, Na Li, Weiyu Hu, Chao Qu, Jingyu Cao. Predictive Value of Hepatic Steatosis for Postoperative Recurrence in Hepatitis B-Related Hepatocellular Carcinoma: Development of a Machine Learning-Based Prognostic Model. Journal of Hepatocellular Carcinoma 2025; : 2459 doi: 10.2147/JHC.S536629
161
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine. World Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
162
Han Wang, You-Wen Qian, Yun Zhao, Xia Sheng, Chun-Yan Xia, Hong-Zhen Chen, Wen-Ming Cong, Miao-Xia He, Hui Dong. A Grading System of Intratumoral Tertiary Lymphoid Structure for Combined Hepatocellular-Cholangiocarcinoma: A Multicenter Pathological Study. Journal of Hepatocellular Carcinoma 2025; : 3011 doi: 10.2147/JHC.S568933
163
Rui Zhang, Mingze Li, Shan Lu, Anni Wang, Shujun Zhang. Molecular mechanism of LncRNA MALAT1 in regulating hepatocellular carcinoma progression via the miR-383-5p/PRKAG1 axis and its role in the tumor immune microenvironment. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1613596
164
Zhanao He, Jie Zhang, Wukui Huang. Diagnostic role and immune correlates of programmed cell death-related genes in hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47560-4
165
Okjoo Lee, Jaehong Jeong, So Kyung Yoon, Jun Chul Chung, Jongman Kim, Kwang-Woong Lee, Hyung Chul Kim. Association of primary hepatocellular carcinoma laterality with oncological outcomes for hepatic resection patients: A retrospective, multicenter, propensity score-matched study. Asian Journal of Surgery 2025; 48(4): 2241 doi: 10.1016/j.asjsur.2024.12.065
166
Kunpeng Cao, Liuxi Wu, Xinyue Wang, Hongyan Deng, Ya Yuan, Lu Li, Chaoli Xu, Xinhua Ye. Risk Factors for Early Recurrence After Radical Resection of Hepatocellular Carcinoma Based on Preoperative Contrast-Enhanced Ultrasound and Clinical Features. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241281327
167
Longxing Wang, Zhiming Zhao, Kunxian Shu, Mingyue Ma. MPCD Index for Hepatocellular Carcinoma Patients Based on Mitochondrial Function and Cell Death Patterns. International Journal of Molecular Sciences 2024; 26(1): 118 doi: 10.3390/ijms26010118
168
Xinru Wen, Xianling Wang, Qing Yao, Simin Chen, Chengwei Li, Congyang Zheng, Ang Huang, Xiaoyan Zhan, Zhaofang Bai, Xiaohe Xiao. Hypericin impedes M2 macrophage polarization and protects against Hepatocellular carcinoma. Molecular Immunology 2025; 181: 160 doi: 10.1016/j.molimm.2025.03.012
169
Hiroto Chiba, Naoya Sato, Atsushi Ozeki, Ryota Sugawara, Takayasu Azuma, Shigeyuki Tsukida, Makoto Muto, Junichiro Haga, Yasuhide Kofunato, Teruhide Ishigame, Takashi Kimura, Akira Kenjo, Shigeru Marubashi. Prognostic significance of the liver stiffness value on magnetic resonance imaging elastography in patients undergoing hepatectomy for hepatocellular carcinoma. Surgery Today 2025; 55(10): 1361 doi: 10.1007/s00595-025-03034-w
170
Francesco Vasuri, Stefano Chillotti, Thais Maloberti, Elisa Albertini, Giuliana Germinario, Matteo Cescon, Matteo Ravaioli, Dario de Biase, Antonia D’Errico. Beyond histology: A tissue algorithm predictive of post-surgical recurrence in hepatocellular carcinomas, including TERT promoter mutation. Virchows Archiv 2025; 486(2): 365 doi: 10.1007/s00428-024-03791-y
171
Matheus D. Faleiro, Zuhaib M. Mir, Yara Azizieh, Stephanie E. Hiebert, Scott M. Livingstone, Mark J. Walsh, Boris L. Gala-Lopez. Oncologic Outcomes of Interventions to Decrease Allograft Ischemia-Reperfusion Injury within Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review. Current Oncology 2024; 31(6): 2895 doi: 10.3390/curroncol31060221
172
Parissa Tabrizian, Adriana Pero, Myron Schwartz. Hepatic Resection for Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1): 59 doi: 10.1016/j.cld.2024.08.008
173
Zhihao Huang, Jiakun Wang, Aoxiao He, Qian Feng, Jun Yang, Linquan Wu, Wenjun Liao. NCAPG confers ferroptosis resistance of hepatocellular carcinoma through NSUN2-mediated m5C modification. Cellular Signalling 2026; 138: 112256 doi: 10.1016/j.cellsig.2025.112256
174
Kai-En Liu, Ya-Li Huang, Jin-Hua Chen, Tsai-Wei Huang, Yi-No Kang, Min-Huei Hsu, Hoang Khanh Dinh, Chiehfeng Chen. Comparative survival outcomes of laparoscopic liver resection and radiofrequency ablation for hepatocellular carcinoma: a retrospective propensity-score-matched cohort study. International Journal of Surgery 2026; 112(3): 5687 doi: 10.1097/JS9.0000000000004113
175
Elisa Pinto, Alberto Zanetto, Martina Gambato, Alberto Ferrarese, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra. NON-TUMOR-RELATED RISKS OF POST-TRANSPLANT HEPATOCELLULAR CARCINOMA (HCC) RECURRENCE: A STATE-OF-THE-ART REVIEW. European Journal of Transplantation 2025; 3(2): 63 doi: 10.57603/EJT-1749
176
Yong-hai Li, Gui-xiang Qian, Yu Zhu, Xue-di Lei, Lei Tang, Xiang-yi Bu, Ming-tong Wei, Wei-dong Jia. An Integrated Model Combined Conventional Radiomics and Deep Learning Features to Predict Early Recurrence of Hepatocellular Carcinoma Eligible for Curative Ablation: A Multicenter Cohort Study. Journal of Computer Assisted Tomography 2025; 49(6): 860 doi: 10.1097/RCT.0000000000001764
177
Jiahao Li, Yingnan Liu, Yuqi Qiu, Chao Qu, Jiarui Li. Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1487353
178
Xinyu Yue, Meihuan Fu, Song Yu, Huayue Shi, Simo Cheng, Xiaofeng Zhai. Traditional herbal medicine as an adjuvant therapy for preventing the recurrence of hepatocellular carcinoma after radical resection: Development and validation of a machine learning prediction model. European Journal of Integrative Medicine 2025; 78: 102535 doi: 10.1016/j.eujim.2025.102535
179
Yao Chen, Qiang Zhang, Ming-Yang Zhang. Deep learning techniques for using computed tomography imaging for hepatocellular carcinoma diagnosis, treatment and prognosis. World Journal of Gastroenterology 2026; 32(5): 113592 doi: 10.3748/wjg.v32.i5.113592
180
Shuai He, Wenjie Lou, Junwei Zhao, Yuxing Ni, Haijun Du, Xiyuan Yang. Prophylactic Interventional Therapy After Hepatectomy for Primary Liver Cancer: A Clinical Comparative Study of FOLFOX-HAIC and TACE. Hepatitis Monthly 2025; 25(1) doi: 10.5812/hepatmon-160901
181
Mutaz Jamal Al‐khreisat, Munthar Kadhim‐Abosaoda, Namim Abas Ibrahim, Ms Malathi.H, Priya Priyadarshini‐Nayak, V. Sathiya‐Priya, Gurjant Singh, Ashish Singh Chauhan. Circulating Tumor Cells as Diagnostic and Therapeutic Biomarkers in Hepatocellular Carcinoma: Advancing Precision Oncology Through Liquid Biopsy. Journal of Gastroenterology and Hepatology 2026; 41(2): 556 doi: 10.1111/jgh.70197
182
Priya Acharya, Cecilia Calnan, Afaf Girgis, Miriam Tania Levy. ‘I need to know, just put me in the picture’: a qualitative study of the lived experiences and supportive care needs of patients with hepatocellular carcinoma. Frontline Gastroenterology 2025; 16(2): 137 doi: 10.1136/flgastro-2024-102796
183
Chih-Yang Hsiao, Rey-Heng Hu, Po-Chin Liang, Chih-Horng Wu. Comparison of Long-Term Outcomes Between Repeated Hepatic Resection and Radiofrequency Ablation in Patients with Small Recurrent Hepatocellular Carcinoma After Initial Curative Resection: A Propensity Score Matched Study. Journal of Hepatocellular Carcinoma 2025; : 1587 doi: 10.2147/JHC.S496470
184
Chunlong Zhao, Zheyu Zhou, Jiarun Zhang, Shuya Cao, Jiawei Xu, Cheng Wang, Jun Chen, Xiaoliang Xu, Chaobo Chen, Bing Han. A novel dynamic nomogram based on contrast-enhanced computed tomography radiomics for prediction of glypican-3-positive hepatocellular carcinoma. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1640697
185
Rami Rhaiem, Ammar Abdo, Julien Calderaro, Safi Dokmak, Astrid Herrero, Cyprien Toubert, Perrine Zimmermann, Alexandra Heurgué, Camille Boulagnon-Rombi, Giuliana Amaddeo, Alain Luciani, Hélène Regnault, Marie Alaux, Mickael Lesurtel, Valérie Paradis, Daniele Sommacale, Olivier Soubrane, Stefano Caruso, Rudy Merieux, Reza Kianmanesh, Raffaele Brustia. Machine Learning Models for Disease-Free Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Multicentric French Collaborative Study. Liver Cancer 2026; : 1 doi: 10.1159/000550554
186
Zichen Yu, Wenli Cao, Chengfei Du, Jie Liu, Liping Peng, Fangqiang Wei. Developing a novel predictive model for identifying risk factors associated with being lost to follow-up among high-risk patients for recurrence following radical resection of hepatocellular carcinoma: the first report. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14030-1
187
V. V. Breder, I. A. Pokataev, V. V. Petkau, M. Yu. Fedyanin, E. V. Ledin, V. E. Zagainov, S. V. Shapoval, D. A. Granov, P. V. Balakhnin, N. E. Kudashkin, I. V. Pogrebnyakov, N. V. Popova, E. A. Moroz. Advisory board resolution: The role of the adjuvant atezolizumab plus bevacizumab in patients with hepatocellular carcinoma at high risk of recurrence following surgical resection or ablation. Meditsinskiy sovet = Medical Council 2024; (22): 20 doi: 10.21518/ms2023-450
188
Rokas Stulpinas, Ieva Jakiunaite, Agne Sidabraite, Allan Rasmusson, Dovile Zilenaite-Petrulaitiene, Kestutis Strupas, Arvydas Laurinavicius, Aiste Gulla. Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan Criteria. Current Oncology 2024; 31(9): 5344 doi: 10.3390/curroncol31090394
189
Qingchen Meng, Xiaohang Li, Hongxin Lang. Efficacy of repeat hepatectomy versus radiofrequency ablation for recurrent hepatocellular carcinoma: a Systematic Review and meta-analysis. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1559491
190
Himanshu Kumar, Kanika Vashisht, Shavinder Kumari, Rimpi Arora, Pratima Ashawat, Mahendra Singh Ashawat, Shiv Kumar Kushawaha. From membranes to medicine: Emerging insights into Ezrin’s Role in human disease — A comprehensive overview. Acta Histochemica 2026; 128(1): 152314 doi: 10.1016/j.acthis.2025.152314
191
Yingxia Jing, Yunlong Wu. Sex-determining region Y-Box 4 promotes the progression of advanced hepatocellular carcinoma and enhances regulatory T-cell infiltration and immune suppression. Cytojournal 2025; 22: 56 doi: 10.25259/Cytojournal_27_2025
192
Muhammad Suleman, Hira Arbab, Hadi M. Yassine, Abrar Mohammad Sayaf, Usama Ilahi, Mohammed Alissa, Abdullah Alghamdi, Suad A. Alghamdi, Sergio Crovella, Abdullah A. Shaito. Repurposing Nirmatrelvir for Hepatocellular Carcinoma: Network Pharmacology and Molecular Dynamics Simulations Identify HDAC3 as a Key Molecular Target. Pharmaceuticals 2025; 18(8): 1144 doi: 10.3390/ph18081144
193
Jiaying Qu, Zhuoxia Li, Huiying Zhong, Li Peng, Didi Chen, Min Li, Jean Felix Mukerabigwi, Yu Cao. ND-TPE-COOH: Protein-activated fluorescent diagnostic probes for rapid identification and resection of liver tumors. Sensors and Actuators B: Chemical 2025; 442: 138094 doi: 10.1016/j.snb.2025.138094
194
Wei-Qiao Zhang, Qiao Zhang, Li Tan, Zhi-Feng Guan, Feng Tian, Hong-Tao Tang, Kun He, Wei-Qiang Chen. Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1289916
195
Dan Chen, Ayinuer Aierken, Hui Li, Ruihua Chen, Lei Ren, Kai Wang. Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1232390
196
Ahmed Shehta, Tharwat S. Kandil, El-Sayed AbouEl-Magd, Mohamed Medhat, Mai M. Rizk, Tarek Salah, Ahmed Farouk. Patterns and predictors of recurrence after curative liver resection for hepatocellular carcinoma: Insights from a single Egyptian center. The American Journal of Surgery 2026; 256: 116933 doi: 10.1016/j.amjsurg.2026.116933
197
Lei Tang, Jun Zhao, Rongyuan Liang, Jiale Yang, Caiwei Chen, Zhonghuo Chen, Xiaofei Tao, Jianwei Yi, Taozhi Yu, Kai Wang. HAUS1-mediated activation of CDK4 transcription enhances proliferation, invasion and migration in hepatocellular carcinoma. Cancer Gene Therapy 2026;  doi: 10.1038/s41417-026-01014-x
198
Yuliang Zhang, Xiyue Deng, Kaiyue Cao, Yang Li. Focal nodular hyperplasia combined with hepatocellular carcinoma with bone metastasis: a case report and literature review. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1671301
199
Hao Li, Lixue Qiao, Minyu Kong, Haoran Fang, Zhiping Yan, Ran Guo, Wenzhi Guo. Construction and validation of a prognostic signature based on microvascular invasion and immune-related genes in hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-78467-3
200
Jiajing Zhao, Yunjian Meng, Zhongyi Jiang, Zhike Li, Youyao Li, Yuanjun Liu, Yuandi Zeng, Shaobo Dai, Zhiyong Du, Liping Liu. Construction and Validation of a Predictive Model for Post-TACE Recurrence Risk in Hepatocellular Carcinoma: A Retrospective Cohort Study. Journal of Hepatocellular Carcinoma 2026; : 1 doi: 10.2147/JHC.S584698
201
Lingbo Hu, Xuemei Li, Changhong Yang, Baoyong Zhou, Chengyou Du, Ning Jiang. Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1390938
202
Yingfei Wei, Guixiang Qian, Tao Meng, Zhong Tong. Changes in perioperative serum transaminase levels: predicting early recurrence after hepatectomy for hepatocellular carcinoma. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1589884
203
Boram Lee, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho, Hae Won Lee, Yeshong Park, Hyelim Joo, Seung Yeon Lim. The Obesity Paradox in Hepatocellular Carcinoma: Insights from Continuous and Interaction-Based Analyses of Body Mass Index After Hepatic Resection. Cancers 2026; 18(7): 1143 doi: 10.3390/cancers18071143
204
Yu-Chih Wu, Yen-Chiao Huang, Yung-Che Kuo, Mai-Huong Thi Ngo, Kam-Fai Lee, Yen-Tseng Sung, Hsiao-Feng Wang, Shin-Lian Doong, Liang-Mou Kuo, Te-Sheng Chang, Yen-Hua Huang. HBV X protein regulates cancer stemness and tumor invasiveness through SENP1 in hepatocellular carcinoma. JHEP Reports 2026; 8(1): 101620 doi: 10.1016/j.jhepr.2025.101620
205
Jiaxin Li, Yukun Sun, Ziniu Liu, Jianwen Huang, Jian Wu, Yun Huang, Yali Gao, Baomin Chen, Qiang He. Adjuvant tyrosine kinase inhibitors plus anti-PD-1 therapy reduce recurrence in high-risk hepatocellular carcinoma after resection. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1710602
206
Yuki Nakayama, Kazuki Takeishi, Shinji Itoh, Takashi Motomura, Takeo Toshima, Kyohei Yugawa, Takahiro Tomiyama, Yuriko Tsutsui, Katsuya Toshida, Takuma Ishikawa, Junya Mita, Takeshi Kurihara, Alejandro Soto‐Gutierrez, Tomoharu Yoshizumi. Patatin‐Like Phospholipase Domain Containing 3 I148M Variant Affects Hepatocellular Carcinoma Recurrence After Liver Resection. Liver International 2026; 46(3) doi: 10.1111/liv.70531
207
Abdullah K. Malik, Daniel Geh, Thomas R. Jeffry Evans, Pierce K. H. Chow, Derek A. Mann, Steven A. White. Improving surgical treatments for hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2026; 23(3): 208 doi: 10.1038/s41575-025-01143-y
208
Xinguo Sun, Jianxin Zhang, Qiong Yan, Xiaojun Deng. HDAC7 aggravates malignant proliferation of hepatocellular carcinoma cells via the TRIM26/CBX4 axis. Molecular Genetics and Genomics 2026; 301(1) doi: 10.1007/s00438-026-02363-w
209
Chang-Yi Lu, Kun-Feng Tsai, Chia-Jui Yen, Chueh-Jung Hsieh, Pey-Jey Peng, Shao-Chang Huang, Meng-Rong Chuang, Chi-Jen Chu. Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01599-x
210
Jian-Hong Zhong. Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new era. World Journal of Gastroenterology 2024; 30(8): 806-810 doi: 10.3748/wjg.v30.i8.806
211
Riccardo Nevola, Augusto Delle Femine, Valerio Rosato, Loreta Anesti Kondili, Maria Alfano, Davide Mastrocinque, Simona Imbriani, Pasquale Perillo, Domenico Beccia, Angela Villani, Rachele Ruocco, Livio Criscuolo, Marco La Montagna, Antonio Russo, Aldo Marrone, Ferdinando Carlo Sasso, Raffaele Marfella, Luca Rinaldi, Nicolino Esposito, Giuseppe Barberis, Ernesto Claar. Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?. Cancers 2023; 15(11): 2950 doi: 10.3390/cancers15112950
212
Kai Li, Jing Zhang, Fei Liu. Postoperative adjuvant management in hepatocellular carcinoma: A review of therapeutic efficacy and prognostic outcomes. World Journal of Hepatology 2025; 17(9): 107631 doi: 10.4254/wjh.v17.i9.107631
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.